← Back to Screener
Prenetics Global Limited Class A Ordinary Share (PRE)
Price$17.94
Favorite Metrics
Price vs S&P 500 (26W)15.87%
Price vs S&P 500 (4W)-19.07%
Market Capitalization$298.70M
All Metrics
Book Value / Share (Quarterly)$15.43
P/TBV (Annual)1.71x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-30.56%
Cash Flow / Share (Quarterly)$1.07
Price vs S&P 500 (YTD)10.06%
Gross Margin (TTM)59.47%
Net Profit Margin (TTM)-76.91%
EPS (TTM)$-4.02
10-Day Avg Trading Volume0.14M
EPS Excl Extra (TTM)$-4.02
Revenue Growth (5Y)58.62%
EPS (Annual)$-4.15
ROI (Annual)-33.07%
Gross Margin (Annual)52.98%
Net Profit Margin (5Y Avg)-97.33%
Cash / Share (Quarterly)$5.43
Revenue Growth QoQ (YoY)-89.62%
ROA (Last FY)-28.66%
Revenue Growth TTM (YoY)-77.95%
EBITD / Share (TTM)$-3.78
ROE (5Y Avg)-35.49%
Operating Margin (TTM)-50.09%
Cash Flow / Share (Annual)$-6.85
P/B Ratio1.71x
P/B Ratio (Quarterly)1.27x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)7.34x
Net Interest Coverage (TTM)-29.45x
ROA (TTM)-29.05%
EPS Incl Extra (Annual)$-4.15
Current Ratio (Annual)3.01x
Quick Ratio (Quarterly)2.76x
3-Month Avg Trading Volume0.22M
52-Week Price Return378.44%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$11.48
P/S Ratio (Annual)3.23x
Asset Turnover (Annual)0.45x
52-Week High$23.63
Operating Margin (5Y Avg)-66.27%
EPS Excl Extra (Annual)$-4.15
CapEx CAGR (5Y)77.92%
26-Week Price Return19.85%
Quick Ratio (Annual)2.76x
13-Week Price Return12.13%
Total Debt / Equity (Annual)0.01x
Current Ratio (Quarterly)3.01x
Enterprise Value$268.341
Revenue / Share Growth (5Y)39.53%
Asset Turnover (TTM)0.18x
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)6.38x
Pretax Margin (Annual)-59.45%
Cash / Share (Annual)$5.43
3-Month Return Std Dev91.20%
Gross Margin (5Y Avg)44.02%
Net Income / Employee (TTM)$-0
ROE (Last FY)-33.40%
Net Interest Coverage (Annual)-29.43x
EPS Basic Excl Extra (Annual)$-4.15
Receivables Turnover (TTM)1.47x
EV / Free Cash Flow (TTM)33.75x
Total Debt / Equity (Quarterly)0.01x
EPS Incl Extra (TTM)$-4.02
Receivables Turnover (Annual)22.48x
ROI (TTM)-35.38%
P/S Ratio (TTM)8.17x
Pretax Margin (5Y Avg)-90.85%
Revenue / Share (Annual)$6.57
Tangible BV / Share (Annual)$11.48
Price vs S&P 500 (52W)348.61%
Year-to-Date Return12.70%
5-Day Price Return1.60%
EPS Normalized (Annual)$-4.15
ROA (5Y Avg)-50.65%
Net Profit Margin (Annual)-63.13%
Month-to-Date Return-8.13%
Cash Flow / Share (TTM)$-2.78
EBITD / Share (Annual)$-3.59
Operating Margin (Annual)-46.44%
LT Debt / Equity (Annual)0.00x
P/CF (TTM)18.33x
ROI (5Y Avg)-34.31%
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-4.02
P/TBV (Quarterly)1.71x
P/B Ratio (Annual)1.27x
Inventory Turnover (TTM)6.38x
Pretax Margin (TTM)-77.60%
Book Value / Share (Annual)$15.43
Price vs S&P 500 (13W)11.44%
Beta0.18x
P/FCF (Annual)36.56x
Revenue / Share (TTM)$2.28
ROE (TTM)-36.02%
52-Week Low$3.45
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.00
4.00
4.00
4.00
Industry Peers — Lab Analytical Instruments(22)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
PREPrenetics Global Limited Class A Ordinary Share | 8.17x | 58.62% | 59.47% | -50.09% | $17.94 |
AAgilent Technologies Inc. | 4.74x | 5.41% | 52.60% | 20.40% | $118.25 |
WATWaters Corp | 10.04x | 6.00% | 59.28% | 25.36% | $319.04 |
MTDMettler-Toledo International | 6.50x | 5.47% | 59.37% | 26.05% | $1290.84 |
ILMNIllumina Inc | 4.62x | 6.04% | 66.61% | 18.44% | $132.72 |
RVTYRevvity, Inc. | 3.64x | -5.46% | 54.77% | 12.49% | $89.53 |
BIOBio-Rad Laboratories, Inc.Class A | 3.06x | 0.29% | 52.01% | 1.59% | $291.09 |
BIO.BBio-Rad Laboratories, Inc. Class B | 3.06x | 0.29% | 52.01% | 1.59% | $277.00 |
BRKRPBruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A | 1.75x | 11.57% | 47.13% | 1.40% | $306.06 |
BRKRBruker Corporation | 1.73x | 11.57% | 47.13% | 1.40% | $38.94 |
AVTRAvantor, Inc. | 0.86x | 0.49% | 32.65% | -3.83% | $8.26 |
About
Prenetics Global Ltd is a diversified health sciences company operating three consumer healthcare brands: IM8 (a fast-growing supplement brand), Europa (sports distribution in the USA), and CircleDNA (direct-to-consumer DNA testing). The company has established a Bitcoin treasury with an initial approximately $20 million investment and a board-approved comprehensive digital asset strategy, positioning itself at the intersection of healthcare innovation and digital assets.